FindTrial
Sign In

MT10109L

DRUG4 trials

Sponsors

Medy-Tox

Conditions

Glabellar LinesLateral Canthal Lines

Phase 3

MT10109L in the Treatment of Glabellar Lines (GL) With or Without Concurrent Treatment of Lateral Canthal Lines (LCL)
CompletedNCT03721016
Medy-ToxGlabellar Lines, Lateral Canthal Lines
Start: 2018-10-26End: 2021-01-22Updated: 2023-05-25
MT10109L in the Treatment of Lateral Canthal Lines With or Without Concurrent Treatment of Glabellar Lines
CompletedNCT03732833
Medy-ToxGlabellar Lines, Lateral Canthal Lines
Start: 2018-11-05End: 2021-01-25Updated: 2023-07-17
MT10109L in the Treatment of Lateral Canthal Lines
CompletedNCT03785145
Medy-ToxLateral Canthal Lines
Start: 2018-12-20End: 2021-01-25Updated: 2023-10-05
MT10109L in the Treatment of Glabellar Lines
CompletedNCT03795922
Medy-ToxGlabellar Lines
Start: 2018-12-24End: 2021-01-25Updated: 2023-07-27